106 related articles for article (PubMed ID: 12428428)
1. Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol.
Dun Y; Zhi JM; Sun HY; Zhao RR; Zhao ZQ
Methods Find Exp Clin Pharmacol; 2002 Sep; 24(7):403-12. PubMed ID: 12428428
[TBL] [Abstract][Full Text] [Related]
2. Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation.
Biffl WL; Carnaggio R; Moore EE; Ciesla DJ; Johnson JL; Silliman CC
Surgery; 2003 Jul; 134(1):86-91. PubMed ID: 12874587
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.
Yue TL; Ma XL; Wang X; Romanic AM; Liu GL; Louden C; Gu JL; Kumar S; Poste G; Ruffolo RR; Feuerstein GZ
Circ Res; 1998 Feb; 82(2):166-74. PubMed ID: 9468187
[TBL] [Abstract][Full Text] [Related]
4. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury.
Park KM; Teoh JP; Wang Y; Broskova Z; Bayoumi AS; Tang Y; Su H; Weintraub NL; Kim IM
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H371-83. PubMed ID: 27288437
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway.
Romeo F; Li D; Shi M; Mehta JL
Cardiovasc Res; 2000 Feb; 45(3):788-94. PubMed ID: 10728402
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.
Ma XL; Kumar S; Gao F; Louden CS; Lopez BL; Christopher TA; Wang C; Lee JC; Feuerstein GZ; Yue TL
Circulation; 1999 Apr; 99(13):1685-91. PubMed ID: 10190877
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p38 mitogen activated protein kinase increases lipopolysaccharide induced inhibition of apoptosis in neutrophils by activating extracellular signal-regulated kinase.
Sheth K; Friel J; Nolan B; Bankey P
Surgery; 2001 Aug; 130(2):242-8. PubMed ID: 11490356
[TBL] [Abstract][Full Text] [Related]
10. Effect of carvedilol on cardiomyocyte apoptosis in a rat model of myocardial infarction: a role for toll-like receptor 4.
Liu Q; Zhang J; Xu Y; Huang Y; Wu C
Indian J Pharmacol; 2013; 45(5):458-63. PubMed ID: 24130379
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase.
Spallarossa P; Altieri P; Garibaldi S; Ghigliotti G; Barisione C; Manca V; Fabbi P; Ballestrero A; Brunelli C; Barsotti A
Cardiovasc Res; 2006 Feb; 69(3):736-45. PubMed ID: 16213474
[TBL] [Abstract][Full Text] [Related]
12. Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes.
Iwai-Kanai E; Hasegawa K; Sawamura T; Fujita M; Yanazume T; Toyokuni S; Adachi S; Kihara Y; Sasayama S
Circulation; 2001 Dec; 104(24):2948-54. PubMed ID: 11739311
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I inhibits cardiomyocyte apoptosis and the underlying signal transduction pathways.
Sun HY; Zhao RR; Zhi JM
Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):601-7. PubMed ID: 11256230
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis--new opportunities for novel therapeutics for heart diseases.
Feuerstein GZ
Cardiovasc Drugs Ther; 2001 Nov; 15(6):547-51. PubMed ID: 11916364
[TBL] [Abstract][Full Text] [Related]
15. Suppression of PMN apoptosis by hypoxia is dependent on Mcl-1 and MAPK activity.
Leuenroth SJ; Grutkoski PS; Ayala A; Simms HH
Surgery; 2000 Aug; 128(2):171-7. PubMed ID: 10922988
[TBL] [Abstract][Full Text] [Related]
16. Effects of carvedilol on cardiomyocyte apoptosis and gene expression in vivo after ischemia-reperfusion in rats.
Zeng H; Liu X; Zhao H
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):127-30. PubMed ID: 12973927
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
Yeh CH; Chen TP; Wang YC; Lin YM; Fang SW
Shock; 2013 Apr; 39(4):343-52. PubMed ID: 23481492
[TBL] [Abstract][Full Text] [Related]
18. SB203580 reverses adrenomedullin's effect on proliferation and apoptosis in cultured mesangial cells.
Parameswaran N; Spielman WS; Brooks DP; Nambi P
Eur J Pharmacol; 1999 Apr; 371(1):75-82. PubMed ID: 10355597
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol inhibits platelet-derived growth factor-induced extracellular matrix synthesis by inhibiting cellular reactive oxygen species and mitogen-activated protein kinase activation.
Park J; Ha H; Kim MS; Ahn HJ; Huh KH; Kim YS
J Heart Lung Transplant; 2006 Jun; 25(6):683-9. PubMed ID: 16730574
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart.
Schwarz ER; Kersting PH; Reffelmann T; Meven DA; Al-Dashti R; Skobel EC; Klosterhalfen B; Hanrath P
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):207-15. PubMed ID: 14506546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
